Digoxin: Difference between revisions
| Line 9: | Line 9: | ||
==Category== | ==Category== | ||
Cardiac [[glycosides]]. | |||
==US Brand Names== | ==US Brand Names== | ||
Revision as of 21:08, 22 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
For patient information, click here.
Overview
Digoxin INN is a purified cardiac glycoside similar to Digitoxin extracted from the foxglove plant, Digitalis lanata,[1] which was discovered by William Withering. Its corresponding aglycone is digoxigenin, and its acetyl derivative is acetyldigoxin. Digoxin is widely used in the treatment of various heart conditions, namely atrial fibrillation, atrial flutter and sometimes heart failure that cannot be controlled by other medication.
Category
Cardiac glycosides.
US Brand Names
LANOXIN®, DIGOXIN®
FDA Package Insert
| Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
References
- ↑ Hollman A (1996). "Digoxin comes from Digitalis lanata". British Medical Journal. 312 (7035): 912.